UniProt ID | MO4L1_HUMAN | |
---|---|---|
UniProt AC | Q9UBU8 | |
Protein Name | Mortality factor 4-like protein 1 | |
Gene Name | MORF4L1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 362 | |
Subcellular Localization | Nucleus. | |
Protein Description | Component of the NuA4 histone acetyltransferase (HAT) complex which is involved in transcriptional activation of select genes principally by acetylation of nucleosomal histones H4 and H2A. This modification may both alter nucleosome - DNA interactions and promote interaction of the modified histones with other proteins which positively regulate transcription. This complex may be required for the activation of transcriptional programs associated with oncogene and proto-oncogene mediated growth induction, tumor suppressor mediated growth arrest and replicative senescence, apoptosis, and DNA repair. The NuA4 complex ATPase and helicase activities seem to be, at least in part, contributed by the association of RUVBL1 and RUVBL2 with EP400. NuA4 may also play a direct role in DNA repair when directly recruited to sites of DNA damage. Also component of the mSin3A complex which acts to repress transcription by deacetylation of nucleosomal histones. Required for homologous recombination repair (HRR) and resistance to mitomycin C (MMC). Involved in the localization of PALB2, BRCA2 and RAD51, but not BRCA1, to DNA-damage foci.. | |
Protein Sequence | MAPKQDPKPKFQEGERVLCFHGPLLYEAKCVKVAIKDKQVKYFIHYSGWNKKSAVRPRRSEKSLKTHEDIVALFPVPEGAPSVHHPLLTSSWDEWVPESRVLKYVDTNLQKQRELQKANQEQYAEGKMRGAAPGKKTSGLQQKNVEVKTKKNKQKTPGNGDGGSTSETPQPPRKKRARVDPTVENEETFMNRVEVKVKIPEELKPWLVDDWDLITRQKQLFYLPAKKNVDSILEDYANYKKSRGNTDNKEYAVNEVVAGIKEYFNVMLGTQLLYKFERPQYAEILADHPDAPMSQVYGAPHLLRLFVRIGAMLAYTPLDEKSLALLLNYLHDFLKYLAKNSATLFSASDYEVAPPEYHRKAV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
9 | Ubiquitination | APKQDPKPKFQEGER CCCCCCCCCCCCCCE | 48.35 | 27667366 | |
10 | Ubiquitination | PKQDPKPKFQEGERV CCCCCCCCCCCCCEE | 66.85 | 33845483 | |
16 | Acetylation | PKFQEGERVLCFHGP CCCCCCCEEEEECCC | 37.25 | 19608861 | |
16 | Ubiquitination | PKFQEGERVLCFHGP CCCCCCCEEEEECCC | 37.25 | 23000965 | |
21 | Ubiquitination | GERVLCFHGPLLYEA CCEEEEECCCEEEEE | 35.64 | 23000965 | |
28 | Ubiquitination | HGPLLYEAKCVKVAI CCCEEEEEEEEEEEE | 9.29 | 33845483 | |
29 | Acetylation | GPLLYEAKCVKVAIK CCEEEEEEEEEEEEC | 27.85 | 26051181 | |
29 | Ubiquitination | GPLLYEAKCVKVAIK CCEEEEEEEEEEEEC | 27.85 | 32015554 | |
32 | Ubiquitination | LYEAKCVKVAIKDKQ EEEEEEEEEEECCCE | 35.10 | 33845483 | |
36 | Ubiquitination | KCVKVAIKDKQVKYF EEEEEEECCCEEEEE | 49.49 | 27667366 | |
38 | Ubiquitination | VKVAIKDKQVKYFIH EEEEECCCEEEEEEE | 52.57 | - | |
42 | Phosphorylation | IKDKQVKYFIHYSGW ECCCEEEEEEEECCC | 14.65 | 26074081 | |
46 | Phosphorylation | QVKYFIHYSGWNKKS EEEEEEEECCCCCCC | 12.22 | 26074081 | |
47 | Phosphorylation | VKYFIHYSGWNKKSA EEEEEEECCCCCCCC | 24.14 | 26074081 | |
47 | Ubiquitination | VKYFIHYSGWNKKSA EEEEEEECCCCCCCC | 24.14 | 29967540 | |
47 (in isoform 2) | Phosphorylation | - | 24.14 | 25159151 | |
48 | Ubiquitination | KYFIHYSGWNKKSAV EEEEEECCCCCCCCC | 25.47 | 29967540 | |
51 | Ubiquitination | IHYSGWNKKSAVRPR EEECCCCCCCCCCCC | 41.41 | 29967540 | |
53 | Phosphorylation | YSGWNKKSAVRPRRS ECCCCCCCCCCCCCC | 33.34 | 26074081 | |
60 | Phosphorylation | SAVRPRRSEKSLKTH CCCCCCCCHHHCCCC | 51.13 | 26074081 | |
64 | Ubiquitination | PRRSEKSLKTHEDIV CCCCHHHCCCCHHEE | 12.58 | 21890473 | |
64 (in isoform 2) | Ubiquitination | - | 12.58 | 21890473 | |
69 | Ubiquitination | KSLKTHEDIVALFPV HHCCCCHHEEEHEEC | 32.81 | 29967540 | |
71 | Ubiquitination | LKTHEDIVALFPVPE CCCCHHEEEHEECCC | 6.15 | 33845483 | |
72 | Ubiquitination | KTHEDIVALFPVPEG CCCHHEEEHEECCCC | 12.10 | 23000965 | |
72 (in isoform 2) | Ubiquitination | - | 12.10 | 21890473 | |
77 | Ubiquitination | IVALFPVPEGAPSVH EEEHEECCCCCCCCC | 34.24 | 23503661 | |
78 | Ubiquitination | VALFPVPEGAPSVHH EEHEECCCCCCCCCC | 69.12 | 23000965 | |
78 (in isoform 2) | Ubiquitination | - | 69.12 | 21890473 | |
88 | Ubiquitination | PSVHHPLLTSSWDEW CCCCCCCCCCCHHHC | 5.27 | 22817900 | |
88 (in isoform 2) | Ubiquitination | - | 5.27 | 21890473 | |
91 | Ubiquitination | HHPLLTSSWDEWVPE CCCCCCCCHHHCCCH | 33.05 | 33845483 | |
97 | Ubiquitination | SSWDEWVPESRVLKY CCHHHCCCHHHHHHH | 34.61 | 33845483 | |
99 | Ubiquitination | WDEWVPESRVLKYVD HHHCCCHHHHHHHHH | 22.94 | 21890473 | |
99 | Ubiquitination | WDEWVPESRVLKYVD HHHCCCHHHHHHHHH | 22.94 | 27667366 | |
100 | Ubiquitination | DEWVPESRVLKYVDT HHCCCHHHHHHHHHH | 35.80 | 33845483 | |
103 | Acetylation | VPESRVLKYVDTNLQ CCHHHHHHHHHHHHH | 40.13 | 26051181 | |
103 | Ubiquitination | VPESRVLKYVDTNLQ CCHHHHHHHHHHHHH | 40.13 | 22817900 | |
103 (in isoform 1) | Ubiquitination | - | 40.13 | 21890473 | |
104 | Acetylation | PESRVLKYVDTNLQK CHHHHHHHHHHHHHH | 10.21 | 19608861 | |
104 | Ubiquitination | PESRVLKYVDTNLQK CHHHHHHHHHHHHHH | 10.21 | 23000965 | |
104 (in isoform 2) | Ubiquitination | - | 10.21 | 21890473 | |
109 | Ubiquitination | LKYVDTNLQKQRELQ HHHHHHHHHHHHHHH | 7.95 | 23000965 | |
111 | Ubiquitination | YVDTNLQKQRELQKA HHHHHHHHHHHHHHH | 55.26 | 23000965 | |
111 (in isoform 1) | Ubiquitination | - | 55.26 | 21890473 | |
113 | Ubiquitination | DTNLQKQRELQKANQ HHHHHHHHHHHHHHH | 54.34 | 21890473 | |
113 | Ubiquitination | DTNLQKQRELQKANQ HHHHHHHHHHHHHHH | 54.34 | 22817900 | |
114 | Ubiquitination | TNLQKQRELQKANQE HHHHHHHHHHHHHHH | 53.73 | 21890473 | |
114 | Ubiquitination | TNLQKQRELQKANQE HHHHHHHHHHHHHHH | 53.73 | 21890473 | |
116 | Ubiquitination | LQKQRELQKANQEQY HHHHHHHHHHHHHHH | 37.75 | 33845483 | |
117 | Ubiquitination | QKQRELQKANQEQYA HHHHHHHHHHHHHHH | 63.03 | 23000965 | |
117 (in isoform 1) | Ubiquitination | - | 63.03 | 21890473 | |
122 | Ubiquitination | LQKANQEQYAEGKMR HHHHHHHHHHHHHCC | 32.73 | 21890473 | |
122 | Ubiquitination | LQKANQEQYAEGKMR HHHHHHHHHHHHHCC | 32.73 | 23000965 | |
123 | Phosphorylation | QKANQEQYAEGKMRG HHHHHHHHHHHHCCC | 13.08 | - | |
127 | Acetylation | QEQYAEGKMRGAAPG HHHHHHHHCCCCCCC | 19.54 | 25953088 | |
127 | Ubiquitination | QEQYAEGKMRGAAPG HHHHHHHHCCCCCCC | 19.54 | 21906983 | |
127 (in isoform 1) | Ubiquitination | - | 19.54 | 21890473 | |
135 | Ubiquitination | MRGAAPGKKTSGLQQ CCCCCCCCCCCCCHH | 52.39 | 29967540 | |
136 | Ubiquitination | RGAAPGKKTSGLQQK CCCCCCCCCCCCHHC | 54.56 | 33845483 | |
143 | Acetylation | KTSGLQQKNVEVKTK CCCCCHHCCCEEEEC | 50.42 | 19608861 | |
143 | Ubiquitination | KTSGLQQKNVEVKTK CCCCCHHCCCEEEEC | 50.42 | 23000965 | |
143 (in isoform 1) | Ubiquitination | - | 50.42 | 21890473 | |
148 | Ubiquitination | QQKNVEVKTKKNKQK HHCCCEEEECCCCCC | 40.91 | 23000965 | |
155 | Ubiquitination | KTKKNKQKTPGNGDG EECCCCCCCCCCCCC | 59.29 | 33845483 | |
156 | Phosphorylation | TKKNKQKTPGNGDGG ECCCCCCCCCCCCCC | 33.65 | 21815630 | |
157 | Ubiquitination | KKNKQKTPGNGDGGS CCCCCCCCCCCCCCC | 41.09 | 29967540 | |
159 | Ubiquitination | NKQKTPGNGDGGSTS CCCCCCCCCCCCCCC | 46.73 | 33845483 | |
164 | Phosphorylation | PGNGDGGSTSETPQP CCCCCCCCCCCCCCC | 34.00 | 21712546 | |
165 | Ubiquitination | GNGDGGSTSETPQPP CCCCCCCCCCCCCCC | 33.58 | 23503661 | |
165 (in isoform 2) | Ubiquitination | - | 33.58 | - | |
166 | Phosphorylation | NGDGGSTSETPQPPR CCCCCCCCCCCCCCC | 40.96 | 25159151 | |
168 | Phosphorylation | DGGSTSETPQPPRKK CCCCCCCCCCCCCCC | 27.30 | 21815630 | |
174 | Ubiquitination | ETPQPPRKKRARVDP CCCCCCCCCCCCCCC | 53.00 | 29967540 | |
175 | Ubiquitination | TPQPPRKKRARVDPT CCCCCCCCCCCCCCC | 53.20 | 29967540 | |
179 | Ubiquitination | PRKKRARVDPTVENE CCCCCCCCCCCCCCH | 11.45 | 33845483 | |
187 | Ubiquitination | DPTVENEETFMNRVE CCCCCCHHHHHHCEE | 59.95 | 27667366 | |
187 (in isoform 2) | Ubiquitination | - | 59.95 | 21890473 | |
188 | Ubiquitination | PTVENEETFMNRVEV CCCCCHHHHHHCEEE | 23.23 | 33845483 | |
190 | Sulfoxidation | VENEETFMNRVEVKV CCCHHHHHHCEEEEE | 4.01 | 21406390 | |
196 | Ubiquitination | FMNRVEVKVKIPEEL HHHCEEEEEECCHHH | 25.06 | 29967540 | |
198 | Ubiquitination | NRVEVKVKIPEELKP HCEEEEEECCHHHCC | 46.99 | 33845483 | |
201 | Ubiquitination | EVKVKIPEELKPWLV EEEEECCHHHCCHHC | 78.44 | 22817900 | |
201 (in isoform 2) | Ubiquitination | - | 78.44 | 21890473 | |
202 | Ubiquitination | VKVKIPEELKPWLVD EEEECCHHHCCHHCC | 57.66 | 21890473 | |
202 (in isoform 2) | Ubiquitination | - | 57.66 | 21890473 | |
204 | Ubiquitination | VKIPEELKPWLVDDW EECCHHHCCHHCCCH | 37.11 | 23503661 | |
208 | Ubiquitination | EELKPWLVDDWDLIT HHHCCHHCCCHHHHH | 5.76 | 23000965 | |
210 | Ubiquitination | LKPWLVDDWDLITRQ HCCHHCCCHHHHHHH | 33.05 | 23000965 | |
210 (in isoform 2) | Ubiquitination | - | 33.05 | 21890473 | |
212 | Ubiquitination | PWLVDDWDLITRQKQ CHHCCCHHHHHHHHH | 34.88 | 23000965 | |
218 | Ubiquitination | WDLITRQKQLFYLPA HHHHHHHHHHEECCC | 45.75 | 33845483 | |
226 | Acetylation | QLFYLPAKKNVDSIL HHEECCCCCCHHHHH | 42.83 | 25953088 | |
226 | Ubiquitination | QLFYLPAKKNVDSIL HHEECCCCCCHHHHH | 42.83 | 27667366 | |
226 (in isoform 1) | Ubiquitination | - | 42.83 | 21890473 | |
227 | Ubiquitination | LFYLPAKKNVDSILE HEECCCCCCHHHHHH | 65.39 | 22817900 | |
236 | Phosphorylation | VDSILEDYANYKKSR HHHHHHHHHHHHHHC | 6.33 | - | |
239 | Phosphorylation | ILEDYANYKKSRGNT HHHHHHHHHHHCCCC | 16.18 | - | |
240 | Acetylation | LEDYANYKKSRGNTD HHHHHHHHHHCCCCC | 44.04 | 25953088 | |
240 | Ubiquitination | LEDYANYKKSRGNTD HHHHHHHHHHCCCCC | 44.04 | 22817900 | |
240 (in isoform 1) | Ubiquitination | - | 44.04 | 21890473 | |
241 | Ubiquitination | EDYANYKKSRGNTDN HHHHHHHHHCCCCCC | 34.72 | 22817900 | |
241 (in isoform 1) | Ubiquitination | - | 34.72 | 21890473 | |
249 | Ubiquitination | SRGNTDNKEYAVNEV HCCCCCCHHHHHHHH | 55.71 | 23000965 | |
249 (in isoform 1) | Ubiquitination | - | 55.71 | 21890473 | |
296 | Ubiquitination | PDAPMSQVYGAPHLL CCCCHHHHHCHHHHH | 3.59 | 23000965 | |
300 | Ubiquitination | MSQVYGAPHLLRLFV HHHHHCHHHHHHHHH | 17.81 | 23000965 | |
300 (in isoform 2) | Ubiquitination | - | 17.81 | - | |
312 | Sulfoxidation | LFVRIGAMLAYTPLD HHHHHHCHHHCCCCC | 1.53 | 28183972 | |
315 | Phosphorylation | RIGAMLAYTPLDEKS HHHCHHHCCCCCHHH | 12.62 | 19835603 | |
316 | Phosphorylation | IGAMLAYTPLDEKSL HHCHHHCCCCCHHHH | 16.27 | 19835603 | |
335 | Ubiquitination | NYLHDFLKYLAKNSA HHHHHHHHHHHHCCC | 37.91 | 23000965 | |
339 | Ubiquitination | DFLKYLAKNSATLFS HHHHHHHHCCCCCCC | 49.17 | 23000965 | |
348 | Phosphorylation | SATLFSASDYEVAPP CCCCCCCCCCCCCCH | 39.26 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MO4L1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MO4L1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MO4L1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-143, AND MASS SPECTROMETRY. |